Nanoco Group PLC

Non-Executive Director Appointment

RNS Number : 0969J
Nanoco Group PLC
19 August 2021


Nanoco Group PLC

( " Nanoco, the " Group", or the " Company")

Non-Executive Director Appointment


Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials emanating from its technology platform, today announces that it has appointed Henry Turcan to the Company's Board in the role of non-executive director with effect from 1 September 2021.

Henry is a fund manager at Lombard Odier Asset Management (Europe) Limited, Nanoco's largest shareholder, with a focus on active engagement with the companies in which it invests. He has been advising and investing in UK smaller companies for over 20 years and has extensive experience of assisting public companies in creating value for all stakeholders.

Dr Chris Richards, Chairman of Nanoco, commented:

"I am delighted to welcome Henry to the Board of Nanoco. As a significant shareholder representative, Henry has been closely involved with Nanoco for a number of years. The additional capital markets experience he brings to the Company will further support the Board's efforts as we work to deliver maximum shareholder value from our organic business activities and litigation against Samsung during a potentially transformational period for the Company."

Disclosures required pursuant to Listing Rule 9.6.13: Henry Arthur John Turcan has held directorships in the last five years in the following publicly quoted companies:



Arena Events Plc

Woodbois Limited

Minds + Machines Group Limited

Eland Oil & Gas plc

The Stanley Gibbons Group PLC


Mr Turcan does not personally hold any shares in the Company. However, he is a representative of the funds managed or sub-advised by Lombard Odier Asset Management group entities, the Company's largest shareholder, which currently holds 27.04% of Nanoco's shares in issue.

There are no further disclosure requirements under Listing Rule 9.6.13 in respect of these appointments.

- Ends -

For further information, please contact:

Nanoco Group PLC :  +44 (0) 161 603 7900

Brian Tenner, CEO

Liam Gray, UK FD and & Company Secretary

Caroline Watson, Investor Relations Manager

[email protected]


Peel Hunt:

Edward Knight  +44 (0) 20 7418 8900

James Smith


MHP Communications :  +44 (0) 203 128 8570

Reg Hoare

Pete Lambie

[email protected]


Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: .



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.